Literature DB >> 22375014

Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells.

Junko Murai1, Shar-yin N Huang, Benu Brata Das, Thomas S Dexheimer, Shunichi Takeda, Yves Pommier.   

Abstract

Tyrosyl-DNA phosphodiesterase 1 (Tdp1) repairs topoisomerase I cleavage complexes (Top1cc) by hydrolyzing their 3'-phosphotyrosyl DNA bonds and repairs bleomycin-induced DNA damage by hydrolyzing 3'-phosphoglycolates. Yeast Tdp1 has also been implicated in the repair of topoisomerase II-DNA cleavage complexes (Top2cc). To determine whether vertebrate Tdp1 is involved in the repair of various DNA end-blocking lesions, we generated Tdp1 knock-out cells in chicken DT40 cells (Tdp1-/-) and Tdp1-complemented DT40 cells with human TDP1. We found that Tdp1-/- cells were not only hypersensitive to camptothecin and bleomycin but also to etoposide, methyl methanesulfonate (MMS), H(2)O(2), and ionizing radiation. We also show they were deficient in mitochondrial Tdp1 activity. In biochemical assays, recombinant human TDP1 was found to process 5'-phosphotyrosyl DNA ends when they mimic the 5'-overhangs of Top2cc. Tdp1 also processes 3'-deoxyribose phosphates generated from hydrolysis of abasic sites, which is consistent with the hypersensitivity of Tdp1-/- cells to MMS and H(2)O(2). Because recent studies established that CtIP together with BRCA1 also repairs topoisomerase-mediated DNA damage, we generated dual Tdp1-CtIP-deficient DT40 cells. Our results show that Tdp1 and CtIP act in parallel pathways for the repair of Top1cc and MMS-induced lesions but are epistatic for Top2cc. Together, our findings reveal a broad involvement of Tdp1 in DNA repair and clarify the role of human TDP1 in the repair of Top2-induced DNA damage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22375014      PMCID: PMC3339927          DOI: 10.1074/jbc.M111.333963

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

1.  Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5'-phosphorylated DNA double-strand breaks by replication runoff.

Authors:  D Strumberg; A A Pilon; M Smith; R Hickey; L Malkas; Y Pommier
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

Review 2.  Topoisomerase I-mediated DNA damage.

Authors:  P Pourquier; Y Pommier
Journal:  Adv Cancer Res       Date:  2001       Impact factor: 6.242

Review 3.  DNA topoisomerases: structure, function, and mechanism.

Authors:  J J Champoux
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 4.  DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.

Authors:  Yves Pommier; Elisabetta Leo; HongLiang Zhang; Christophe Marchand
Journal:  Chem Biol       Date:  2010-05-28

5.  Processing of nucleopeptides mimicking the topoisomerase I-DNA covalent complex by tyrosyl-DNA phosphodiesterase.

Authors:  Laurent Debéthune; Glenda Kohlhagen; Anna Grandas; Yves Pommier
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

6.  Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae.

Authors:  J J Pouliot; C A Robertson; H A Nash
Journal:  Genes Cells       Date:  2001-08       Impact factor: 1.891

7.  Conversion of phosphoglycolate to phosphate termini on 3' overhangs of DNA double strand breaks by the human tyrosyl-DNA phosphodiesterase hTdp1.

Authors:  Kedar V Inamdar; Jeffrey J Pouliot; Tong Zhou; Susan P Lees-Miller; Aghdass Rasouli-Nia; Lawrence F Povirk
Journal:  J Biol Chem       Date:  2002-05-21       Impact factor: 5.157

8.  Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy.

Authors:  Hiroshi Takashima; Cornelius F Boerkoel; Joy John; Gulam Mustafa Saifi; Mustafa A M Salih; Dawna Armstrong; Yuxin Mao; Florante A Quiocho; Benjamin B Roa; Masanori Nakagawa; David W Stockton; James R Lupski
Journal:  Nat Genet       Date:  2002-09-16       Impact factor: 38.330

9.  The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase.

Authors:  Thomas S Dexheimer; Andrew G Stephen; Matthew J Fivash; Robert J Fisher; Yves Pommier
Journal:  Nucleic Acids Res       Date:  2010-01-21       Impact factor: 16.971

10.  Collaborative action of Brca1 and CtIP in elimination of covalent modifications from double-strand breaks to facilitate subsequent break repair.

Authors:  Kyoko Nakamura; Toshiaki Kogame; Hiroyuki Oshiumi; Akira Shinohara; Yoshiki Sumitomo; Keli Agama; Yves Pommier; Kimiko M Tsutsui; Ken Tsutsui; Edgar Hartsuiker; Tomoo Ogi; Shunichi Takeda; Yoshihito Taniguchi
Journal:  PLoS Genet       Date:  2010-01-22       Impact factor: 5.917

View more
  79 in total

1.  Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.

Authors:  Trung Xuan Nguyen; Andrew Morrell; Martin Conda-Sheridan; Christophe Marchand; Keli Agama; Alun Bermingham; Alun Bermingam; Andrew G Stephen; Adel Chergui; Alena Naumova; Robert Fisher; Barry R O'Keefe; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2012-04-26       Impact factor: 7.446

Review 2.  Tyrosyl-DNA-phosphodiesterases (TDP1 and TDP2).

Authors:  Yves Pommier; Shar-yin N Huang; Rui Gao; Benu Brata Das; Junko Murai; Christophe Marchand
Journal:  DNA Repair (Amst)       Date:  2014-05-22

3.  TDP1 promotes assembly of non-homologous end joining protein complexes on DNA.

Authors:  Jinho Heo; Jing Li; Matthew Summerlin; Annette Hays; Sachin Katyal; Peter J McKinnon; Karin C Nitiss; John L Nitiss; Leslyn A Hanakahi
Journal:  DNA Repair (Amst)       Date:  2015-03-17

4.  Identification of a ligand binding hot spot and structural motifs replicating aspects of tyrosyl-DNA phosphodiesterase I (TDP1) phosphoryl recognition by crystallographic fragment cocktail screening.

Authors:  George T Lountos; Xue Zhi Zhao; Evgeny Kiselev; Joseph E Tropea; Danielle Needle; Yves Pommier; Terrence R Burke; David S Waugh
Journal:  Nucleic Acids Res       Date:  2019-11-04       Impact factor: 16.971

5.  TDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors.

Authors:  Muthana Al Abo; Hiroyuki Sasanuma; Xiaojun Liu; Vinodh N Rajapakse; Shar-Yin Huang; Evgeny Kiselev; Shunichi Takeda; William Plunkett; Yves Pommier
Journal:  Mol Cancer Ther       Date:  2017-08-11       Impact factor: 6.261

6.  Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.

Authors:  Trung Xuan Nguyen; Monica Abdelmalak; Christophe Marchand; Keli Agama; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2015-03-26       Impact factor: 7.446

7.  Biochemical assays for the discovery of TDP1 inhibitors.

Authors:  Christophe Marchand; Shar-yin N Huang; Thomas S Dexheimer; Wendy A Lea; Bryan T Mott; Adel Chergui; Alena Naumova; Andrew G Stephen; Andrew S Rosenthal; Ganesha Rai; Junko Murai; Rui Gao; David J Maloney; Ajit Jadhav; William L Jorgensen; Anton Simeonov; Yves Pommier
Journal:  Mol Cancer Ther       Date:  2014-07-14       Impact factor: 6.261

8.  Identification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platform.

Authors:  Junko Murai; Christophe Marchand; Sampada A Shahane; Hongmao Sun; Ruili Huang; Yiping Zhang; Adel Chergui; Jiuping Ji; James H Doroshow; Ajit Jadhav; Shunichi Takeda; Menghang Xia; Yves Pommier
Journal:  DNA Repair (Amst)       Date:  2014-04-29

Review 9.  Drugging topoisomerases: lessons and challenges.

Authors:  Yves Pommier
Journal:  ACS Chem Biol       Date:  2013-01-04       Impact factor: 5.100

10.  Rationale for poly(ADP-ribose) polymerase (PARP) inhibitors in combination therapy with camptothecins or temozolomide based on PARP trapping versus catalytic inhibition.

Authors:  Junko Murai; Yiping Zhang; Joel Morris; Jiuping Ji; Shunichi Takeda; James H Doroshow; Yves Pommier
Journal:  J Pharmacol Exp Ther       Date:  2014-03-20       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.